David A. Cooper

35.7k citations

440 papers · 24.0k indexed · 7 hit papers · h-index 75

Impact in

Virology top 0.01%
- HIV Research and Treatment
Emergency Medicine top 0.01%
- HIV-related health complications and treatments

Papers in

Virology 251
- HIV Research and Treatment 248
Infectious Diseases 263
- HIV/AIDS Research and Interventions 176
- HIV/AIDS drug development and treatment 153

Co-authors: Andrew Carr Katherine Samaras Donald J. Chisholm Matthew Law Anthony D. Kelleher John Zaunders Ronald Penny Judith Freund
Journals: AIDS (70 papers)The Journal of Infectious Diseases (33 papers)The Medical Journal of Australia (29 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (21 papers)AIDS Research and Human Retroviruses (18 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

David A. Cooper

429 papers receiving 23.0k citations

Hit Papers

7 papers align trajectories log scale

Antiretroviral Treatment for Adult HIV Infection in 2002 2002 · 573 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 JAMA
2000 JAMA
2000 AIDS
1999 The Lancet
1998 JAMA
1998 The Lancet
1998 AIDS

Peers

Countries citing papers authored by David A. Cooper

Since Specialization

Citations

This map shows the geographic impact of David A. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Cooper more than expected).

Fields of papers citing papers by David A. Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Cooper. The network helps show where David A. Cooper may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David A. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Cooper Line = papers co-authored together David A. Cooper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bacterial Influence on Pharmacokinetics of Tacrolimus and Sulfasalazine through Regulation of Host Metabolism Advanced Therapeutics ·David A. Cooper, Abhinav Bhushan	2024	1
2	Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial BMC Public Health ·(unknown), Iryna Zablotska, Christine Selvey, Rebecca Guy, Karen Price, Jo Holden, H Schmidt, Anna McNulty, David J. Smith, Fengyi Jin, Janaki Amin, David A. Cooper, Andrew E. Grulich	2018	53
3	Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy AIDS Research and Human Retroviruses ·Cecilia Wallseth, Yin Xu, Fadiga Nazario Aimar Deafiga, Michelle Bailey, Kazuo Suzuki, Shufu Yu, Retaj Elferjany, John Bergelin, Andrew Field, Andrew Carr, Mark Bloch, David A. Cooper, Anthony D. Kelleher, John Zaunders, Kersten K. Koelsch	2017	25
4	HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells Frontiers in Immunology ·Yin Xu, Chansavath Phetsouphanh, Kazuo Suzuki, Claire Winnie NGA NDONGO, Stéphanie Graff‐Dubois, Michael Roche, Michelle Bailey, Sheilajen Alcântara, Nobuyuki Mizukoshi, Rahuram Sivasubramaniam, Kersten K. Koelsch, Brigitte Autran, Richard J. Harvey, Paul R. Gorry, Arnaud Moris, David A. Cooper, Stuart Turville, Stephen J. Kent, Anthony D. Kelleher, John Zaunders	2017	23
5	Determinants of Suicide and Accidental or Violent Death in the Australian HIV Observational Database PLoS ONE ·Hamish McManus, Kathy Petoumenos, Subin Moon, Mark D. Kelly, Jo Watson, Catherine OʼConnor, Cyn-Young, Jennifer Hoy, David A. Cooper, Matthew Law, (unknown)	2014	25
6	Assessing adherence in Thai patients taking combination antiretroviral therapy International Journal of STD & AIDS ·Stephen J. Kerr, Anchalee Avihingsanon, Opass Putcharoen, Ploenchan Chetchotisakd, Suci Nur Alima, Sasiwimol Ubolyam, Kiat Ruxrungtham, David A. Cooper, Praphan Phanuphak, Chris Duncombe	2012	15
7	Predictors of Limb Fat Gain in HIV Positive Patients Following a Change to Tenofovir-Emtricitabine or Abacavir-Lamivudine PLoS ONE ·Allison Martin, Janaki Amin, Sean Emery, David Baker, Andrew Carr, David A. Cooper, Mark Bloch	2011	14
8	Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cells Nucleic Acids Research ·Chantelle Ahlenstiel, Catherine Le ferrand, David A. Cooper, Takaomi Ishida, Anthony D. Kelleher, Kazuo Suzuki	2011	63
9	Poor Baseline Immune Function Predicts an Incomplete Immune Response to Combination Antiretroviral Treatment Despite Sustained Viral Suppression JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kathleen Falster, Kathy Petoumenos, John Chuah, Anne Mijch, Brian P. Mulhall, Mark Kelly, David A. Cooper	2009	29
10	Evolution of CD4 ⁺ T Cell Count in HIV-1-Infected Adults Receiving Antiretroviral Therapy with Sustained Long-Term Virological Suppression AIDS Research and Human Retroviruses ·Helen Byakwaga, John M. Murray, Kathy Petoumenos, Anthony D. Kelleher, Matthew Law, Mark Boyd, Sean Emery, Patrick Mallon, David A. Cooper	2009	8
11	Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research AIDS ·Mark Boyd, David A. Cooper	2007	48
12	Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution Journal of Virology ·Bin Li, Adrianne D. Gladden, Marcus Altfeld, John Kaldor, David A. Cooper, Anthony D. Kelleher, Todd M. Allen	2006	117
13	Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir Pharmacogenetics and Genomics ·Mark Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham, Peter I. Mackenzie, Verawan Uchaipichat, Michael Stek, Joep M. A. Lange, Praphan Phanuphak, David A. Cooper, José Francisco Yarza Sanz, John O. Miners	2006	43
14	In Vivo, Nucleoside Reverse‐Transcriptase Inhibitors Alter Expression of Both Mitochondrial and Lipid Metabolism Genes in the Absence of Depletion of Mitochondrial DNA The Journal of Infectious Diseases ·Patrick Mallon, Patrick Unemori, HeDongjian, Adrienne Morey, Berk Alp Göksel, Kenneth Williams, Donald J. Chisholm, Katherine Samaras, Sean Emery, Anthony D. Kelleher, David A. Cooper, Andrew Carr, (unknown)	2005	140
15	Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection AIDS ·Athanasios Davalas, Sabine Kinloch, Li‐Ean Goh, David A. Cooper, Luc Perrin, Fiona Lampe, John Zaunders, Bruno Hoën, Chris Tsoukas, Jan Andersson, George Janossy	2002	72
16	Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection The Journal of Immunology ·Sharon R. Lewin, Ruy M. Ribeiro, Gilbert R. Kaufmann, Don Smith, John Zaunders, Matthew Law, Ajantha Solomon, Paul Cameron, David A. Cooper, Alan S. Perelson	2002	42
17	Characterization of CD4+ CTLs Ex Vivo The Journal of Immunology ·Victor Appay, John Zaunders, Laura Papagno, Julian Sutton, Andrés Jaramillo, Anele Waters, Philippa Easterbrook, Pat Grey, Don Smith, Andrew J. McMichael, David A. Cooper, Sarah Rowland‐Jones, Anthony D. Kelleher	2002	435
18	Relative Significance of Different Pathways of Immune Reconstitution in HIV Type 1 Infection as Estimated by Mathematical Modeling AIDS Research and Human Retroviruses ·Gilbert R. Kaufmann, John Zaunders, John M. Murray, Anthony D. Kelleher, Sharon R. Lewin, Ajantha Solomon, Don Smith, David A. Cooper	2001	20
19	The role of initial AIDS-defining illness in survival following AIDS AIDS ·Kehui Luo, Matthew Law, John Kaldor, Ann M. McDonald, David A. Cooper	1995	50
20	Expression of B-Type Epstein-Barr Virus in HIV-Infected Patients and Cardiac Transplant Recipients AIDS Research and Human Retroviruses ·D. Frassetto, سليماني زناقي, Orfa Rosana Barazarte Sierra, Denis J. Moss, David A. Cooper, Elizabeth M. Benson, Donald S. Esmore, T B Sculley	1992	42

About David A. Cooper

David A. Cooper is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Immunology and Epidemiology, having authored 440 papers that have together received 24.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (248 papers), HIV/AIDS Research and Interventions (176 papers), HIV/AIDS drug development and treatment (153 papers), HIV-related health complications and treatments (101 papers), Immune Cell Function and Interaction (53 papers), Pneumocystis jirovecii pneumonia detection and treatment (33 papers), HIV, Drug Use, Sexual Risk (29 papers) and T-cell and B-cell Immunology (27 papers). The work is most often cited by research in Virology (12.8k citations), Emergency Medicine (7.6k citations), Infectious Diseases (14.1k citations), Epidemiology (5.9k citations) and Immunology (3.3k citations). David A. Cooper has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew Carr, Katherine Samaras, Donald J. Chisholm, Matthew Law, Anthony D. Kelleher, John Zaunders, Ronald Penny, Judith Freund, Andrew Carr and Gilbert R. Kaufmann. Their work appears in journals such as AIDS, The Journal of Infectious Diseases, The Medical Journal of Australia, JAIDS Journal of Acquired Immune Deficiency Syndromes and AIDS Research and Human Retroviruses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact